mk 0663 has been researched along with Chronic Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asero, R | 2 |
| Gammaitoni, A; Jensen, MP; Peloso, PM; Schnitzer, TJ; Smugar, SS; Wang, H | 1 |
| Lories, RJ | 1 |
| Capell, HA; Duncan, MR | 1 |
| Birbara, CA; Bohidar, NR; Geba, GP; Mangione, A; Munoz, DR; Puopolo, AD; Sheldon, EA | 1 |
| Adler, JL; Bohidar, NR; Ettlinger, RE; Geba, GP; Lipetz, R; Mucciola, L; O'Brien, K; Pallay, RM; Petruschke, RA; Quaidoo, EA; Seger, W; Skalky, CS | 1 |
| Cavanaugh, PF; Dougados, M; Gossec, L; James, MK; Krupa, DA; Melian, A; Reicin, AS; van der Heijde, D | 1 |
| Giezek, H; Grifka, J; Hupli, M; Maini, M; Morales, R; Nilganuwong, S; Ozturk, ZE; Shivaprakash, M; Zerbini, C | 1 |
| Bird, SR; Sheldon, EA; Smugar, SS; Tershakovec, AM | 1 |
1 review(s) available for mk 0663 and Chronic Disease
| Article | Year |
|---|---|
Etoricoxib and the treatment of ankylosing spondylitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Etoricoxib; Gastrointestinal Diseases; Half-Life; Humans; Pain; Pyridines; Spondylitis, Ankylosing; Sulfones | 2012 |
6 trial(s) available for mk 0663 and Chronic Disease
| Article | Year |
|---|---|
Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disability Evaluation; Etoricoxib; Female; Humans; Isoenzymes; Low Back Pain; Male; Membrane Proteins; Middle Aged; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones; Treatment Outcome | 2003 |
Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial.
Topics: Adult; Aged; Chronic Disease; Disabled Persons; Dose-Response Relationship, Drug; Double-Blind Method; Etoricoxib; Female; Humans; Low Back Pain; Male; Middle Aged; Placebos; Pyridines; Quality of Life; Sulfones; Treatment Outcome | 2004 |
Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Male; Middle Aged; Naproxen; Pain Measurement; Pyridines; Severity of Illness Index; Spondylitis, Ankylosing; Sulfones; Treatment Outcome | 2005 |
Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Diclofenac; Double-Blind Method; Etoricoxib; Female; Humans; Low Back Pain; Male; Middle Aged; Pyridines; Sulfones | 2005 |
Etoricoxib challenge in patients with chronic urticaria with NSAID intolerance.
Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Eruptions; Etoricoxib; Female; Humans; Male; Middle Aged; Pyridines; Single-Blind Method; Sulfonamides; Sulfones; Tramadol; Urticaria | 2007 |
Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclooxygenase Inhibitors; Disability Evaluation; Etoricoxib; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Pyridines; ROC Curve; Sulfones; Surveys and Questionnaires; Treatment Outcome | 2008 |
3 other study(ies) available for mk 0663 and Chronic Disease
| Article | Year |
|---|---|
Multiple nonsteroidal anti-inflammatory drug-induced cutaneous disease: what differentiates patients with and without underlying chronic spontaneous urticaria?
Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Diagnosis, Differential; Drug Hypersensitivity; Etoricoxib; Female; Follow-Up Studies; Humans; Immunization; Male; Middle Aged; Pyridines; Sulfones; Tramadol; Urticaria; Young Adult | 2014 |
Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlled trials of etoricoxib.
Topics: Adult; Aged; Chronic Disease; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Pyridines; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Sulfones; Treatment Outcome; Weights and Measures | 2012 |
Etoricoxib in the treatment of chronic pain.
Topics: Adult; Aged; Arthritis; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Double-Blind Method; Etoricoxib; Gastrointestinal Diseases; Humans; Low Back Pain; Middle Aged; Pain; Pyridines; Randomized Controlled Trials as Topic; Sulfones | 2003 |